Related Experiment Video
Updated: Jun 8, 2026
07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
Acute pulmonary embolism. Part 2: treatment
Josien van Es1, Renée A Douma, Victor E A Gerdes
1Department of Vascular Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. j.vanes@amc.uva.nl
Nature Reviews. Cardiology
|September 16, 2010
Summary
Pulmonary embolism (PE) treatment varies by severity, from anticoagulation to thrombolysis for massive PE. Risk stratification and new anticoagulants are under investigation for optimal patient care.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Hematology
Background:
- Pulmonary embolism (PE) presents with diverse clinical symptoms, from mild to severe cardiogenic shock.
- Current PE treatment involves initial anticoagulation and long-term vitamin-K antagonists (VKAs).
Purpose of the Study:
- To review current treatment strategies for pulmonary embolism.
- To discuss risk stratification methods for thrombolysis eligibility.
- To explore emerging therapies and management approaches for PE.
Main Methods:
- Review of existing literature on PE diagnosis and treatment.
- Analysis of current therapeutic guidelines and ongoing research.
- Discussion of risk stratification tools and novel anticoagulant agents.
Main Results:
- Thrombolysis is indicated for massive PE with hemodynamic shock but not conclusively for submassive PE.
- VKA treatment duration is typically 3-12 months, individualized based on recurrence risk and bleeding.
- Low-molecular-weight heparin (LMWH) is recommended for PE patients with malignancy for the first six months.
Conclusions:
- PE management requires tailored approaches based on patient stability and risk factors.
- Further research is needed to establish optimal thrombolysis use and long-term anticoagulation strategies.
- New oral anticoagulants and home-based treatment models show promise for future PE care.
Related Concept Videos
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:27Pulmonary Embolism III: Nursing Management
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations: